Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.34 EUR
7.79 M EUR
141.92 M EUR
14.74 M
About JAPAN MEDICAL DYNAMIC MARKETING
Sector
Industry
Headquarters
Tokyo
Website
Founded
1973
ISIN
JP3689100000
FIGI
BBG000DRRMQ9
Japan Medical Dynamic Marketing, Inc. engages in the development, manufacture, import and sale of medical equipment. Its products include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It also provides introduction of medical products to major hospitals and doctors nationwide. The company was founded on May 28, 1973 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of JMD is 3.70 EUR — it has increased by 2.21% in the past 24 hours. Watch JP.MEDICAL DY.MARK. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange JP.MEDICAL DY.MARK. stocks are traded under the ticker JMD.
JMD stock has risen by 2.78% compared to the previous week, the month change is a −8.87% fall, over the last year JP.MEDICAL DY.MARK. has showed a −12.74% decrease.
JMD stock is 2.16% volatile and has beta coefficient of 0.21. Track JP.MEDICAL DY.MARK. stock price on the chart and check out the list of the most volatile stocks — is JP.MEDICAL DY.MARK. there?
Today JP.MEDICAL DY.MARK. has the market capitalization of 98.18 M, it has increased by 1.10% over the last week.
Yes, you can track JP.MEDICAL DY.MARK. financials in yearly and quarterly reports right on TradingView.
JP.MEDICAL DY.MARK. is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
JP.MEDICAL DY.MARK. revenue for the last quarter amounts to 36.02 M EUR, despite the estimated figure of 37.80 M EUR. In the next quarter, revenue is expected to reach 39.08 M EUR.
JMD net income for the last quarter is 1.39 M EUR, while the quarter before that showed 1.59 M EUR of net income which accounts for −12.17% change. Track more JP.MEDICAL DY.MARK. financial stats to get the full picture.
JP.MEDICAL DY.MARK. dividend yield was 1.90% in 2023, and payout ratio reached 28.98%. The year before the numbers were 1.25% and 24.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has 511.00 employees. See our rating of the largest employees — is JP.MEDICAL DY.MARK. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JP.MEDICAL DY.MARK. EBITDA is 21.50 M EUR, and current EBITDA margin is 14.42%. See more stats in JP.MEDICAL DY.MARK. financial statements.
Like other stocks, JMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JP.MEDICAL DY.MARK. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JP.MEDICAL DY.MARK. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JP.MEDICAL DY.MARK. stock shows the sell signal. See more of JP.MEDICAL DY.MARK. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.